Dataset Information

CuDDI: A CUDA-Based Application for Extracting Drug-Drug Interaction Related Substance Terms from PubMed Literature.

ABSTRACT: Drug-drug interaction (DDI) is becoming a serious issue in clinical pharmacy as the use of multiple medications is more common. The PubMed database is one of the biggest literature resources for DDI studies. It contains over 150,000 journal articles related to DDI and is still expanding at a rapid pace. The extraction of DDI-related information, including compounds and proteins from PubMed, is an essential step for DDI research. In this paper, we introduce a tool, CuDDI (compute unified device architecture-based DDI searching), for identification of DDI-related terms (including compounds and proteins) from PubMed. There are three modules in this application, including the automatic retrieval of substances from PubMed, the identification of DDI-related terms, and the display of relationship of DDI-related terms. For DDI term identification, a speedup of 30?105 times was observed for the compute unified device architecture (CUDA)-based version compared with the implementation with a CPU-based Python version. CuDDI can be used to discover DDI-related terms and relationships of these terms, which has the potential to help clinicians and pharmacists better understand the mechanism of DDIs. CuDDI is available at: https://github.com/chengusf/CuDDI.

SUBMITTER: Lu Y

PROVIDER: S-EPMC6470591 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

CuDDI: A CUDA-Based Application for Extracting Drug-Drug Interaction Related Substance Terms from PubMed Literature.

Lu Yin Y Ramachandra Aditya Chandra Vothgod ACV Pham Minh M Tu Yi-Cheng YC Cheng Feng F

Molecules (Basel, Switzerland) 20190319 6

Drug-drug interaction (DDI) is becoming a serious issue in clinical pharmacy as the use of multiple medications is more common. The PubMed database is one of the biggest literature resources for DDI studies. It contains over 150,000 journal articles related to DDI and is still expanding at a rapid pace. The extraction of DDI-related information, including compounds and proteins from PubMed, is an essential step for DDI research. In this paper, we introduce a tool, CuDDI (compute unified device a ...[more]

PMID: 30893816

Similar Datasets

Project description:BACKGROUND: With the development of high throughput methods of gene analyses, there is a growing need for mining tools to retrieve relevant articles in PubMed. As PubMed grows, literature searches become more complex and time-consuming. Automated search tools with good precision and recall are necessary. We developed GO2PUB to automatically enrich PubMed queries with gene names, symbols and synonyms annotated by a GO term of interest or one of its descendants. RESULTS: GO2PUB enriches PubMed queries based on selected GO terms and keywords. It processes the result and displays the PMID, title, authors, abstract and bibliographic references of the articles. Gene names, symbols and synonyms that have been generated as extra keywords from the GO terms are also highlighted. GO2PUB is based on a semantic expansion of PubMed queries using the semantic inheritance between terms through the GO graph. Two experts manually assessed the relevance of GO2PUB, GoPubMed and PubMed on three queries about lipid metabolism. Experts' agreement was high (kappa?=?0.88). GO2PUB returned 69% of the relevant articles, GoPubMed: 40% and PubMed: 29%. GO2PUB and GoPubMed have 17% of their results in common, corresponding to 24% of the total number of relevant results. 70% of the articles returned by more than one tool were relevant. 36% of the relevant articles were returned only by GO2PUB, 17% only by GoPubMed and 14% only by PubMed. For determining whether these results can be generalized, we generated twenty queries based on random GO terms with a granularity similar to those of the first three queries and compared the proportions of GO2PUB and GoPubMed results. These were respectively of 77% and 40% for the first queries, and of 70% and 38% for the random queries. The two experts also assessed the relevance of seven of the twenty queries (the three related to lipid metabolism and four related to other domains). Expert agreement was high (0.93 and 0.8). GO2PUB and GoPubMed performances were similar to those of the first queries. CONCLUSIONS: We demonstrated that the use of genes annotated by either GO terms of interest or a descendant of these GO terms yields some relevant articles ignored by other tools. The comparison of GO2PUB, based on semantic expansion, with GoPubMed, based on text mining techniques, showed that both tools are complementary. The analysis of the randomly-generated queries suggests that the results obtained about lipid metabolism can be generalized to other biological processes. GO2PUB is available at http://go2pub.genouest.org.

Project description:The recently proposed concept of molecular connectivity maps enables researchers to integrate experimental measurements of genes, proteins, metabolites, and drug compounds under similar biological conditions. The study of these maps provides opportunities for future toxicogenomics and drug discovery applications. We developed a computational framework to build disease-specific drug-protein connectivity maps. We integrated gene/protein and drug connectivity information based on protein interaction networks and literature mining, without requiring gene expression profile information derived from drug perturbation experiments on disease samples. We described the development and application of this computational framework using Alzheimer's Disease (AD) as a primary example in three steps. First, molecular interaction networks were incorporated to reduce bias and improve relevance of AD seed proteins. Second, PubMed abstracts were used to retrieve enriched drug terms that are indirectly associated with AD through molecular mechanistic studies. Third and lastly, a comprehensive AD connectivity map was created by relating enriched drugs and related proteins in literature. We showed that this molecular connectivity map development approach outperformed both curated drug target databases and conventional information retrieval systems. Our initial explorations of the AD connectivity map yielded a new hypothesis that diltiazem and quinidine may be investigated as candidate drugs for AD treatment. Molecular connectivity maps derived computationally can help study molecular signature differences between different classes of drugs in specific disease contexts. To achieve overall good data coverage and quality, a series of statistical methods have been developed to overcome high levels of data noise in biological networks and literature mining results. Further development of computational molecular connectivity maps to cover major disease areas will likely set up a new model for drug development, in which therapeutic/toxicological profiles of candidate drugs can be checked computationally before costly clinical trials begin.

Dataset Information

CuDDI: A CUDA-Based Application for Extracting Drug-Drug Interaction Related Substance Terms from PubMed Literature.

Publications

CuDDI: A CUDA-Based Application for Extracting Drug-Drug Interaction Related Substance Terms from PubMed Literature.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets